• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

ESMO ADC Files

Antibody-drug conjugates were a major biotech headline at the ESMO Congress 2023. Here, we present the ESMO ADC Files, with more on the ADC frenzy.

construction build house in-house worker roof
Biotech

Regeneron stays out of ADC deal fray as scientists tinker

Regeneron is good at making antibodies. But while the industry has gone crazy for ADCs, the company has stayed out of the limelight.
Annalee Armstrong Nov 15, 2023 9:11am
candy Halloween bucket skeleton hand pumpkin

Daiichi Sankyo ups revenue forecast thanks to huge Merck deal

Oct 31, 2023 10:10am
Graphic images of white and black puzzle pieces connecting seamlessly

AbbVie CEO says company favored internal work over Daiichi deal

Oct 27, 2023 11:41am
Merck

Merck hopes internal ADCs reach clinic in 'next couple years'

Oct 26, 2023 11:33am
Daiichi

After Enhertu success, Daiichi and AstraZeneca branch off

Oct 25, 2023 8:00am
Novartis ESMO 2023

Novartis knows what's ahead as peers enter radiopharmaceuticals

Oct 24, 2023 7:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings